Who invested in CMAB Biopharma?
CMAB Biopharma's investors include C-Bridge Capital, BioBAY/ I-Bridge and Qianhai FoF.

China · Series A startup
Funding summaryUpdated 26 Oct 2026
$38Mraised across 1 round since 2017, from 1 source
CMAB Biopharma's investors include C-Bridge Capital, BioBAY/ I-Bridge and Qianhai FoF.
CMAB Biopharma has raised $38M across 1 round since 2017.
CMAB Biopharma's most recent round was a Series A of $38M in Jan 2017.
Its most recent round, $38M in Jan 2017, is also its largest on record.
CMAB Biopharma's first round on record, in Jan 2017, was backed by C-Bridge Capital, BioBAY/ I-Bridge and Qianhai FoF.
CMAB Biopharma's latest named round is a Series A, in Jan 2017.
CMAB Biopharma is based in China.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.